PHCO 737

Target-Based Drug Discovery and Cancer Treatment.

University of North Carolina at Chapel Hill · UGRD · Fall 2026

1 section
Add to a schedule

Catalog description

A lecture/discussion course that emphasizes preclinical and clinical studies for the development of anti-cancer drugs that target signal transduction. Topics include: target identification and validation, drug discovery, the process of government approval for clinical trials, design of clinical trials, and new genetic-based technologies to foster drug development.

Sections

Current meeting, instructor, credit, and enrollment details

Updated 6 hours ago

001

Availability not recently verified
Class #north_carolina_chapel_hill-8013Fall 2026UGRD2 credits
Days & times
No scheduled meeting time
Meeting dates
Location
Instructor
Staff
Class numbers and section codes come from the registrar.
Spot missing or incorrect course data?